Access
To read this story in full you will need to login or make a payment (see right).
News and Views
Nature 450, 803-804 (6 December 2007) | doi:10.1038/nature06363; Published online 18 November 2007
Open Innovation Challenges
-
Methods of Modeling Adaptation in Populations
The analysis of adaptation with a population is a frequently encountered computational modeling scen...
-
Single-cell Analysis Platform
This Challenge is looking for novel approaches to analyzing changes at a single-cell level. This is...
- More Challenges
- Powered by:
nature jobs
Graphic Artist / Flash
- Indegene Lifesystems Pvt. Ltd
- Bengaluru 560 071 India
Clinical Trial Analyst
- Indegene Lifesystems Pvt. Ltd
- Bengaluru 560 071 India
Cancer: Immune pact with the enemy
Cornelis J. M. Melief1
Abstract
Progress comes from the latest investigations into a long-standing question in immunology — the role of the immune system in maintaining small, potentially cancerous lesions in a state of dormancy.
The current belief about treating cancer is that tumour cells need to be eradicated as quickly as possible, so as to halt tumour growth and spread, and to prevent or delay the death of the patient. The startling results of Koebel et al.1 (page 903 of this issue) demonstrate that considering cancer as a fatal disease is not always appropriate*.
- Cornelis J. M. Melief is in the Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, Albinusdreef 2, PO Box 9600, 2300 RC Leiden, the Netherlands.
Email: c.melief@lumc.nl
To read this story in full you will need to login or make a payment (see right).
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
RESEARCH
Induction of MIF synthesis and secretion by tubular epithelial cells: A novel action of angiotensin IIKidney International Original Article
